Literature DB >> 24355530

Further evidence for genetic association of CACNA1C and schizophrenia: new risk loci in a Han Chinese population and a meta-analysis.

Fanfan Zheng1, Yanling Zhang2, Wuxiang Xie3, Wenqiang Li4, Chao Jin5, Weifeng Mi1, Fang Wang1, Wenbin Ma5, Cuicui Ma5, Yongfeng Yang4, Bo Du6, Keqing Li6, Chenxing Liu1, Lifang Wang1, Tianlan Lu1, Hongyan Zhang1, Yun Wang7, Lin Lu8, Luxian Lv4, Dai Zhang9, Weihua Yue10.   

Abstract

CACNA1C (12p13.3) has been implicated as a susceptibility gene for schizophrenia by several replicated genome wide association studies. While these results have been consistent among studies in European populations, the findings in East Asian populations have varied. To test whether CACNA1C is a risk gene for schizophrenia, we conducted a case-control study in 5897 schizophrenic patients and 6323 healthy control subjects selected from Han Chinese population. Our study replicated the positive associations of rs1006737 (P=0.0108, OR=1.16, 95% CI: 1.03-1.29) and rs1024582 (P=0.0062, OR=1.18, 95% CI: 1.05-1.33), and identified a novel risk locus, rs2007044 (P=0.0053, OR=1.08, 95% CI: 1.02-1.14). A meta-analysis of rs1006737 combining our study and previous studies was conducted in a total of 8222 schizophrenia cases and 24,661 healthy controls. In the meta-analysis, the association between rs1006737 and schizophrenia remained significant (OR=1.14, 95% CI: 1.07-1.22, P=0.0001). Stratified analysis showed no heterogeneity between East Asian and European ancestries (χ(2)[1]=0.07, P=0.795), and the difference in pooled ORs between ancestries was not significant (Z=0.25, P=0.801). Our results provide further support for associations of rs1006737 and rs1024582 with schizophrenia, identify a new risk locus rs2007044 in a Han Chinese population, and further establish CACNA1C as an important susceptibility gene for the disease across world populations. Crown
Copyright © 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CACNA1C; Case–control study; Genetic association; Meta-analysis; Schizophrenia; rs1006737

Mesh:

Substances:

Year:  2013        PMID: 24355530     DOI: 10.1016/j.schres.2013.12.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

Review 1.  CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis.

Authors:  Anna L Moon; Niels Haan; Lawrence S Wilkinson; Kerrie L Thomas; Jeremy Hall
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

2.  ZNF804A Variation May Affect Hippocampal-Prefrontal Resting-State Functional Connectivity in Schizophrenic and Healthy Individuals.

Authors:  Yuyanan Zhang; Hao Yan; Jinmin Liao; Hao Yu; Sisi Jiang; Qi Liu; Dai Zhang; Weihua Yue
Journal:  Neurosci Bull       Date:  2018-04-02       Impact factor: 5.203

3.  Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory.

Authors:  Donna Cosgrove; Omar Mothersill; Kimberley Kendall; Bettina Konte; Denise Harold; Ina Giegling; Annette Hartmann; Alex Richards; Kiran Mantripragada; Michael J Owen; Michael C O'Donovan; Michael Gill; Dan Rujescu; James Walters; Aiden Corvin; Derek W Morris; Gary Donohoe
Journal:  Neuropsychopharmacology       Date:  2017-06-13       Impact factor: 7.853

Review 4.  The genomic load of deleterious mutations: relevance to death in infancy and childhood.

Authors:  James Alfred Morris
Journal:  Front Immunol       Date:  2015-03-16       Impact factor: 7.561

5.  Regional brain dysregulation of Ca(2+)-handling systems in ketamine-induced rat model of experimental psychosis.

Authors:  Malwina Lisek; Tomasz Boczek; Bozena Ferenc; Ludmila Zylinska
Journal:  Cell Tissue Res       Date:  2015-12-21       Impact factor: 5.249

Review 6.  Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.

Authors:  Qi Qiu; Jing Huang; Xiaoming Shu; Huizheng Fan; Youwen Zhou; Cheng Xiao
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

7.  Further evidence for the genetic association between CACNA1I and schizophrenia.

Authors:  Yijun Xie; Di Huang; Li Wei; Xiong-Jian Luo
Journal:  Hereditas       Date:  2018-01-02       Impact factor: 3.271

Review 8.  Progress in genome-wide association studies of schizophrenia in Han Chinese populations.

Authors:  Weihua Yue; Xin Yu; Dai Zhang
Journal:  NPJ Schizophr       Date:  2017-08-10

Review 9.  Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.

Authors:  Qi Qiu; Jing Huang; Yang Lin; Xiaoming Shu; Huizheng Fan; Zhihua Tu; Youwen Zhou; Cheng Xiao
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

10.  The effects of a genome-wide supported variant in the CACNA1C gene on cortical morphology in schizophrenia patients and healthy subjects.

Authors:  Fanfan Zheng; Yue Cui; Hao Yan; Bing Liu; Tianzi Jiang
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.